Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
R. Cavallo  Clinical Microbiology and Infection 
Cerebrospinal fluid cytokines in enterovirus 71 brain stem encephalitis and echovirus meningitis infections of varying severity  S.-M. Wang, H.-Y. Lei,
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
Nosocomial infection caused by class 1 integron-carrying Staphylococcus aureus in a hospital in South China  Z. Xu, L. Shi, C. Zhang, L. Zhang, X. Li,
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
The relationship between tumour necrosis factor-α gene polymorphism and susceptibility and clearance of the persistent hepatitis B virus infection in.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
A.K. Reddy, P. Garg, I. Kaur  Clinical Microbiology and Infection 
Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals  G. Ippolito  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Hepatitis B and C virus-related carcinogenesis
Infectious causes of cancer: an evolving educational saga
Virological tools to diagnose and monitor hepatitis C virus infection
Whole genome analysis of Mycobacterium tuberculosis isolates from recurrent episodes of tuberculosis, Finland, 1995–2013  V. Korhonen, P.W. Smit, M. Haanperä,
R. Cantón  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Non-antibiotic strategies for sepsis
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Surveillance of Legionnaires’ disease in Austria
Nosocomial infection caused by class 1 integron-carrying Staphylococcus aureus in a hospital in South China  Z. Xu, L. Shi, C. Zhang, L. Zhang, X. Li,
Analysis of intracellular human immunodeficiency virus (HIV)-1 drug resistance mutations in multi-failed HIV-1-infected patients treated with a salvage.
Vector control: a cornerstone in the malaria elimination campaign
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
Why is mucormycosis more difficult to cure than more common mycoses?
Estimation of delay in detecting hepatitis C virus antibodies in pools compared to individual testing on seroconversion panels  B. Sarov, L. Novack, N.
Laboratory diagnosis and biosafety issues of biological warfare agents
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Elements of design: the knowledge on which we build
Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-α  C.
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
Metagenomics and probiotics
Hepatitis B and C virus-related carcinogenesis
Laboratory diagnosis of Clostridium difficile disease
A. Bryskier  Clinical Microbiology and Infection 
The practice of travel medicine in Europe
T.M. File  Clinical Microbiology and Infection 
Sexually acquired Zika virus: a systematic review
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
P.M. Hawkey  Clinical Microbiology and Infection 
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
Current experience in treating invasive zygomycosis with posaconazole
Antimicrobial drug development – the past, the present, and the future
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS  M. Rybicka,
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Nebulized hypertonic saline treatment in hospitalized children with moderate to severe viral bronchiolitis  Z. Luo, Z. Fu, E. Liu, X. Xu, X. Fu, D. Peng,
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
W. Witte  Clinical Microbiology and Infection 
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response to antiviral treatment  E. Riva, C. Scagnolari, O. Turriziani, G. Antonelli  Clinical Microbiology and Infection  Volume 20, Issue 12, Pages 1237-1245 (December 2014) DOI: 10.1111/1469-0691.12797 Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Interferon (IFN)-λ3 and IFN-λ4 variants on chromosome 19. IL, interleukin; SNP, single-nucleotide polymorphism. Clinical Microbiology and Infection 2014 20, 1237-1245DOI: (10.1111/1469-0691.12797) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.